top of page
Search Results

1096 items found for "GPCR Therapeutics"

Programs (7)

  • GPCRs in Pharmacology

    This comprehensive course is designed to provide an in-depth exploration of key concepts in pharmacology, offering a nuanced understanding of drug interactions and mechanisms of action. The curriculum is divided into four modules, each focusing on essential aspects of pharmacological principles. Whether you are a healthcare professional, researcher, or student in the life sciences, this course will enhance your knowledge and critical thinking skills in the field of pharmacology.

  • Dr. GPCR Ecosystem 2.0

    GPCR Ecosystem.

View All

Posts (535)

  • GPCR Therapeutics Expands Scientific Advisory Board

    May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR GPCR just had a very successful first meeting including all the Scientific Advisory Board." Read more at the source #DrGPCR #GPCR #IndustryNews

  • GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development

    Dr Brennan has extensive experience across all phases of clinical development, and across multiple therapeutic #biotech #lifesciences #appointment #GPCR #Oncology" Read more at the source #DrGPCR #GPCR #IndustryNews

  • Dr. Juan José Fung - Dr. GPCR Podcast

    GPCR Podcast is back this week with a brand new episode. Our guest is none other than Dr. Juan Jose Fung, Principal Scientist, at GPCR Therapeutics. https://buff.ly/32fzGbO #gpcr #drgpcr #podcast

View All

Other Pages (553)

  • Ep 60 with Dr. Josephine (Pina) Cardarelli

    Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers She was an integral contributor to two therapeutics that are FDA approved, Yervoy and Opdivo. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered around therapeutic

  • 23-06 Dr GPCR Newsletter

    GPCR Newsletter June, 2023 Hello Readers, Welcome to our monthly Dr. GPCR Newsletter! GPCR Symposium on Structural and Molecular Insights on GPCR Activation . Ecosystem Partners We thank Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals , Montana Take a look at the latest news classified by topic: Adhesion GPCRs GPCR Activation and Signaling GPCR and Molecular Insights into GPCR Function Industry News Call for GPCR Papers GPCR Events, Meetings,

  • 23-12 Dr GPCR Newsletter

    GPCR Newsletter December, 2023 Hello Readers, Welcome to our monthly Dr. GPCR Newsletter! GPCR Access to Dr. Ecosystem Partners We thank Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals , Montana Take a look at the latest news classified by topic: Adhesion GPCRs GPCR Activation and Signaling GPCR and Molecular Insights into GPCR Function Industry News Call for GPCR Papers GPCR Events, Meetings,

View All
bottom of page